NJ Justices Won't Review Toss Of $25M Accutane Verdict
Law360 (July 23, 2018, 4:13 PM EDT) -- The New Jersey Supreme Court has refused to examine a second appellate opinion overturning a $25.1 million jury verdict against Hoffmann-La Roche Inc. over the adverse effects of the company’s acne drug Accutane, saying a consumer could seek the court’s review down the road, according to an order made available Monday.
After previously reinstating the verdict following the first appellate ruling, the state’s highest court denied the petition for certification filed by plaintiff Andrew McCarrell in challenging the May 2017 decision that reversed the jury award and remanded the matter for a new trial.
The Supreme Court said the justices denied...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!